COCCO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 471
EU - Europa 325
AS - Asia 87
AF - Africa 12
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 906
Nazione #
US - Stati Uniti d'America 464
IT - Italia 99
CN - Cina 44
SE - Svezia 33
FR - Francia 30
DE - Germania 29
IE - Irlanda 29
GB - Regno Unito 23
ES - Italia 20
UA - Ucraina 17
FI - Finlandia 15
SG - Singapore 13
SN - Senegal 11
SA - Arabia Saudita 9
IN - India 7
GR - Grecia 6
KR - Corea 5
VN - Vietnam 5
CA - Canada 4
EU - Europa 4
NL - Olanda 4
AR - Argentina 3
AT - Austria 3
CH - Svizzera 3
LT - Lituania 3
MK - Macedonia 3
TH - Thailandia 3
CL - Cile 2
MX - Messico 2
NO - Norvegia 2
PL - Polonia 2
UY - Uruguay 2
CZ - Repubblica Ceca 1
DM - Dominica 1
EG - Egitto 1
HR - Croazia 1
IR - Iran 1
RO - Romania 1
RU - Federazione Russa 1
Totale 906
Città #
Fremont 90
Chandler 85
Beijing 34
Torino 30
Dublin 27
Ann Arbor 25
Villeurbanne 19
Ashburn 15
Nyköping 13
Dearborn 12
Houston 12
Fairfield 11
Genova 10
Milan 9
Woodbridge 9
Jacksonville 8
Medford 8
Princeton 8
Menlo Park 7
Mountain View 7
Singapore 7
Wilmington 7
Bochum 6
Cambridge 6
Jeddah 6
London 6
Rome 6
Darmstadt 5
Madrid 5
Providence 5
Boston 4
Dong Ket 4
Paris 4
Pisa 4
Bangkok 3
Düsseldorf 3
Elche 3
Mendoza 3
Oulu 3
Redwood City 3
San Diego 3
Toronto 3
Vienna 3
Ashford 2
Aspe 2
Boardman 2
Cardiff 2
Cork 2
Cranston 2
Dallas 2
Ermua 2
Frankfurt am Main 2
Genoa 2
Greenwich 2
Helsinki 2
Ilioupoli 2
Kuopio 2
Montevideo 2
Málaga 2
Nanjing 2
Oberelchingen 2
Palermo 2
Patna 2
Pune 2
Putney 2
Reus 2
Rotterdam 2
Santiago 2
Seattle 2
Sevilla 2
Skopje 2
Stockholm 2
Vilnius 2
Warsaw 2
Washington 2
Wendover 2
Athens 1
Barcelona 1
Biblis 1
Brent 1
Brno 1
Chicago 1
Dornstadt 1
Enfield 1
Favaro Veneto 1
Formia 1
Gostivar 1
Guangzhou 1
Hefei 1
Kharkiv 1
Kunming 1
Kunshan 1
Laval 1
Manchester 1
Mexico City 1
Misinto 1
Montesarchio 1
Naples 1
Norwalk 1
Olbia 1
Totale 631
Nome #
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 220
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 166
T helper subsets changes in alemtuzumab multiple sclerosis treated patients: the recovery of immune system capacity as a possible indicator to treatment 143
Lack of CD4 + T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses 135
To switch therapies in RRMS: why and when? A real-life multicentre study 94
Long Term immunological alemtuzumab effect: increase in Tregsuppressor function 73
Comorbidities affect treatment choice and persistence in RRMS: a real-life multicenter study 73
Switch Strategies in RRMS: A Real-Life Multi Center Study 47
Totale 951
Categoria #
all - tutte 2.215
article - articoli 0
book - libri 0
conference - conferenze 1.317
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 2 0 2 8 4 19 10 6 4 13 6 9
2020/202148 7 4 2 4 3 3 3 4 5 4 4 5
2021/2022107 1 1 2 7 6 6 6 7 2 22 28 19
2022/2023238 13 15 9 34 25 49 6 14 32 6 16 19
2023/2024125 8 20 7 20 15 8 4 18 1 8 2 14
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 951